Astellas Takes Out Massachusetts' Biotech Mitobridge in $390M Deal By Sam | November 30, 2017 Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013. Source: BioSpace Posted in BioPharma